WeinkoveC.Investigation and management of phaeochromocytoma. In: MartinSMHalloranSPGreenAJE, eds. Proceedings of the ACB National Meeting Focus 95. Cambridge: PRC Associates, 1995: 19–21.
2.
SmytheGAEdwardsGGrahamPLazarusL.Biochemical diagnosis of phaeochromocytoma by simultaneous measurement of urinary excretion of epinephrine and norepinephrine. Clin Chem1992; 38: 486–92.
3.
GrahamPESmytheGAEdwardsGALazarusL.Laboratory diagnosis of phaeochromocytoma: Which analytes should we measure?Ann Clin Biochem1993; 30: 129–34.
4.
StewartMFReedPWeinkoveCMoriartyKJRalstonAJ. Biochemical diagnosis of phaeochromocytoma: Two instructive case reports. J Clin Pathol1993; 46: 280–2.
5.
TormeyWPFitzGeraldRJ. Lack of uniformity in the clinical approach to the interpretation of urinary catecholamines and their metabolites. Ir J Med Sci1995; 164: 146–50.
6.
PeastonRTLennardTWJLaiLC. Can overnight excretion of urinary catecholamines and metabolites be used for the detection of phaeochromocytoma? In: MartinSMHalloranSPGreenAJE, eds. Proceedings of the ACB National Meeting 95. Cambridge: PRC Associates, 1995: 172–3.
7.
WeinkoveC.ACP Broadsheet No 127: April 1991. Measurement of catecholamines and their metabolites in urine. J Clin Pathol1991; 44: 269–75.
8.
DavidsonDF. Urinary catecholamine assay by HPLC: In vitro interference by some drugs. Ann Clin Biochem1988; 25: 583–4.
ProyeCFossatiPFontainePDopamine-secreting pheochromocytoma: An unrecognised entity? Classification of pheochromocytomas according to their type of secretion. Surgery1986; 100: 1154–61.
11.
ShepsSGJiangN-SKleeGGvan HeerdenJA. Recent developments in the diagnosis and treatment of pheochromocytoma. Mayo Clin Proc1990; 65: 88–95.